As of November 2024, Regeneron Pharmaceuticals has a market cap of $124.48B. This makes Regeneron Pharmaceuticals the world's 111th valuable company by market cap, according to our data. The market capitalization, also known as a stock market cap is a key financial indication. It represents the combined worth of all the outstanding shares of a publicly traded company multiplied by the current stock price. This figure is often used to see how much a company is worth. This figure is often used to see what is the company net worth.
Year | Market Cap | Change |
---|---|---|
2024 | $102.30B | 8.73% |
2023 | $94.09B | 21.73% |
2022 | $77.29B | 14.25% |
2021 | $67.65B | 30.72% |
2020 | $51.76B | 28.66% |
2019 | $40.22B | 0.53% |
2018 | $40.01B | -0.65% |
2017 | $40.28B | 2.42% |
2016 | $39.33B | -32.38% |
2015 | $58.16B | 32.33% |
2014 | $43.95B | 49.05% |
2013 | $29.49B | 60.89% |
2012 | $18.33B | 208.62% |
2011 | $5.94B | 68.84% |
2010 | $3.52B | 35.77% |
2009 | $2.59B | 31.70% |
2008 | $1.97B | -23.98% |
2007 | $2.59B | 20.33% |
2006 | $2.15B | 26.23% |
2005 | $1.70B | 72.64% |
2004 | $986.66M | -37.39% |
2003 | $1.58B | -20.53% |
2002 | $1.98B | -34.27% |
2001 | $3.02B | -20.15% |
2000 | $3.78B | 176.59% |
1999 | $1.37B | 72.88% |
1998 | $790.08M | -13.87% |
1997 | $917.29M | -46.90% |
1996 | $1.73B | 26.47% |
1995 | $1.37B | 325.00% |
1994 | $321.39M | -80.65% |
1993 | $1.66B | 29.17% |
1992 | $1.29B | -33.79% |
1991 | $1.94B | - |